A clinical trial is conducted to evaluate the efficacy of a new drug to increase HDL cholesterol ("good" cholesterol) in men at high risk for cardiovascular disease. Participants are randomized to receive the new drug or placebo and followed for 12 weeks, at which time HDL cholesterol is measured. The data are summarized in Figure 4-28. 35 FIGURE 4-28 HDL Cholesterol New Drug Placebo What is the Maximum HDL of men who received the Placebo? What is the Range of the HDL of men who received the Placebo? What is the 25 percentile of the HDL of men who received the Placebo?